Pence pitches health plan proposal in Washington
The health insurance expansion Gov. Mike Pence is touting relies on federal Medicaid money and meets federal Medicaid requirements, but the Republican governor insists it's not Medicaid.
Health Care & Life Sciences
Articles
Drugmaker hid diabetes drug’s cancer risks, lawyer says
Takeda Pharmaceutical Co. executives covered up the cancer risks of its diabetes medicine Actos to protect billions of dollars in sales, a lawyer for two women argued.
Indiana’s Obamacare rates for 2015 all over the map
Initial 2015 premiums filed for the Obamacare exchanges in Indiana ranged from as high as a 46-percent hike to as low as a 9-percent cut. Anthem Blue Cross and Blue Shield wants an average increase of 9.7 percent.
Pence’s HIP 2.0 insurance expansion has national aspirations all over it
Gov. Pence's HIP 2.0 plan is nothing less than an attempt to roll back liberal policy on low-income health benefits as far as currently possible–and to get other states to follow suit. It might even be an opening bid for president.
Hospital plans expansion 6 years after flooding
The $30 million project at Columbus Regional Hospital will expand its emergency department and cancer center.
UPDATE: AstraZeneca board rejects new offer from Pfizer
Pfizer’s proposed deal would have been the richest acquisition ever among drugmakers and the third-biggest deal in any industry, according to figures from research firm Dealogic.
Lawmakers positive about Healthy Indiana Plan proposal
An expansion of the Healthy Indiana Plan, which Gov. Mike Pence announced Thursday, received overall positive reviews from Republican and Democratic lawmakers.
Cost-control plan for health care could cost more patients
The Obama administration has given the go-ahead for a new cost-control strategy called "reference pricing." It lets insurers and employers put a dollar limit on what health plans pay for some expensive procedures.
Lilly’s latest sales strategy: the soft sell
Eli Lilly and Co. thinks it has a secret weapon to return to growth. No, it’s not a new blockbuster drug—although Lilly will most likely have several new products hit the market this year and next. Rather, it’s an unorthodox, softer approach put into play by its U.S. sales force.
Marathon talks yield good deal for hospitals in Pence’s HIP expansion
Fees on hospitals will generate the lion’s share of the funds for Gov. Mike Pence’s Healthy Indiana Plan expansion. But the benefits hospitals will receive will outweigh those costs.
UPDATE: Pence unveils Healthy Indiana Plan expansion
Gov. Mike Pence said Medicaid is a "fiscal monstrosity" and hopes a proposed expansion of the state-run Healthy Indiana Plan will pass muster with federal officials as an alternative way to insure low-income residents.
Lilly loses patent dispute over Alimta in London court
Eli Lilly and Co. lost a United Kingdom lawsuit over its Alimta cancer treatment when a judge ruled Thursday that a generic version planned by Actavis Plc doesn’t breach European patents.
UPDATE: Pence to propose 2-tier insurance plan for poor
Officials with direct knowledge of the plan said participants in the first tier would receive limited coverage at no charge. A second tier would include dental and vision coverage and require participant contributions.
WellPoint foe leads plan to reveal health prices to consumers
WellPoint Inc. competitor UnitedHealth Group Inc., the largest U.S. health insurer, will lead an industry effort to throw a spotlight on the prices paid for health-care services, making their costs available to consumers on the Internet.
Pence to unveil multipronged plan to expand health insurance
The governor’s plan, to be announced Thursday, involves a combination of the Healthy Indiana Plan, employer-sponsored health plans and health savings accounts, according to an invitation sent Tuesday to Indiana health care officials.
Community posts healthy results, but short of expectations
Community brought in more revenue and profit from operations last year. But a spike in charity care caused margins to fall significantly short of expectations of Community executives.
Study: Hospital-doctor hook-ups swell prices
Now that Indianapolis-area hospitals employ large numbers of physicians, a new study suggests the integrated health systems will be able to charge higher prices to private health insurers.
Lilly says its once-daily insulin tops competitor’s drug
Eli Lilly & Co. said its experimental insulin helped diabetic patients more than Sanofi’s biggest product in studies that also raised some safety risks.
Algaeon to take big step after landing $2.75M
An Indianapolis-based biotech company plans to use $2.75 million in new funding to begin commercial production of its algae-based nutritional supplements, the firm announced Monday.
U.S. House votes to revive expired research tax credit
The 274-131 vote follows calls to restore the credit by a coalition of companies including Indianapolis-based Eli Lilly and Co. and Texas Instruments Inc.